Carisma Therapeutics Inc.
CARM
Revenue
9.20M
▲5.80M▲170.59%
3 Months ChangeAssets
59.34M
▼-14.46M▼-19.59%
3 Months ChangeLiabilities
58.98M
▼-3.92M▼-6.23%
3 Months ChangeFree Cash Flow
-22.44M
▲3.23M▲12.57%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001104659-24-112629
2024-10-11
Form 8-K
ID: 0001104659-24-108078
2024-08-08
Form 10-Q
ID: 0001485003-24-000015
2024-08-08
Form 8-K
ID: 0001104659-24-087014
2024-07-09
Form 8-K
ID: 0001104659-24-078451
2024-07-02
Form 8-K
ID: 0001104659-24-077372
2024-07-01
Form 8-K
ID: 0001104659-24-076578
2024-06-27
Form 8-K
ID: 0001104659-24-075709
2024-06-14
Form 8-K
ID: 0001104659-24-071796
2024-06-14
Form 8-K
ID: 0001104659-24-071792